Figure 2From: The soluble guanylyl cyclase activator BAY 60-2770 ameliorates detrusor dysfunction in obese miceEffect of chronic treatment with BAY 60-2770 (1 mg/kg, 2 weeks) on cGMP levels (A) and protein expression of α1 (B) and β1 (C) subunits of sGC in bladders from lean + vehicle, lean + BAY 60-2770, obese + vehicle and obese + BAY 60-2770 groups. Data are presented as mean ± SEM. ★p <0.05 in comparison with lean + vehicle group; †p <0.05 in comparison to obese + vehicle group.Back to article page